PDA Cell Substrate Task Force: Emerging Technologies for Virus Detection Technical Document--A Progress Report.
作者信息
King Kathryn, Wiebe Michael
机构信息
FDA Center for Drug Evaluation and Research, Office of Biotechnology Products, Division of Monoclonal Antibodies.
出版信息
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):693. doi: 10.5731/pdajpst.2011.00844.
PMID:22294602
Abstract
CONFERENCE PROCEEDING Proceedings of the PDA/FDA Adventitious Viruses in Biologics: Detection and Mitigation Strategies Workshop in Bethesda, MD, USA; December 1-3, 2010 Guest Editors: Arifa Khan (Bethesda, MD), Patricia Hughes (Bethesda, MD) and Michael Wiebe (San Francisco, CA).
摘要
相似文献
1
PDA Cell Substrate Task Force: Emerging Technologies for Virus Detection Technical Document--A Progress Report.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):693. doi: 10.5731/pdajpst.2011.00844.
2
Introduction to workshop: adventitious viruses in biologics--detection and mitigation strategies.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):544-6. doi: 10.5731/pdajpst.2011.00817.
3
Overview of emerging technologies to detect adventitious agents.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):654-9. doi: 10.5731/pdajpst.2011.00834.
4
A microarray platform for virus detection and identification.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):691. doi: 10.5731/pdajpst.2011.00839.
5
Current European regulations for control of adventitious virus safety.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):568-79. doi: 10.5731/pdajpst.2011.00821.
6
FDA post-approval expectations for adventitious virus contamination prevention.美国食品药品监督管理局（FDA）批准后对预防外来病毒污染的期望。
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):698-712. doi: 10.5731/pdajpst.2011.00846.
7
Application of quality by design in the control of adventitious viruses: gaps in current processes in the prevention of virus contaminants.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):754-66. doi: 10.5731/pdajpst.2011.00849.
8
Identification and remediation of a cell culture virus contamination.细胞培养病毒污染的鉴定与补救。
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):615. doi: 10.5731/pdajpst.2011.00822.
9
Viral Safety of Plasma-derived Products.血浆衍生产品的病毒安全性。
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):737-53. doi: 10.5731/pdajpst.2011.00848.
10
Summary of breakout session e.分组会议E总结
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):616-9. doi: 10.5731/pdajpst.2011.00828.
Zotero 插件